cdx-1140
Showing 1 - 5 of 5
Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)
Recruiting
- Pancreatic Cancer
- +2 more
- CDX-301
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023
Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,
Not yet recruiting
- Biliary Cancer
- +2 more
- oxaliplatin
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 13, 2023
Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)
Completed
- Melanoma
- +25 more
- CDX-1140
- +3 more
-
Scottsdale, Arizona
- +10 more
Sep 27, 2022
Metastatic Triple Negative Breast Cancer Trial in Dallas (PLD Chemotherapy, CDX-1140, CDX-301)
Recruiting
- Metastatic Triple Negative Breast Cancer
- PLD Chemotherapy
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Jun 23, 2022
Malignant Epithelial Tumors Trial in Portland (TCR-transduced T cells, CDX-1140, Pembrolizumab)
Not yet recruiting
- Malignant Epithelial Neoplasms
- TCR-transduced T cells
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Apr 22, 2022